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ABSTRACT
Calcium Supplement Usage and the Potential Health Issues Associated with the
Rate of Usage in Las Vegas, NV
by
Tanesha Nicole Moss
Dr. Michelle Chino, Examination Committee Chair
Professor of Public Health
University of Nevada, Las Vegas
Calcium is a very important nutrient and as such, it is very important that all humans
consume sufficient amounts. However, some calcium supplements have been known to
contain small quantities of lead. This research project used a retrospective approach to
explore the trade-off between the benefits of calcium vs. the potential lead exposure
amongst people who are taking these supplements. A survey consisting of 10 questions
was used to try to assess the rate of consumption of specific types of calcium
supplements. This research project obtained lead levels in calcium supplements from
previous research and applied that data into this research project using the assumption
that the levels were consistent to currents levels of lead in calcium supplements. The
Mann-Whitney and Chi-Square tests were used to analyze the data, since it was
determined that the continuous variables in the data were non-normal and the other
variables were categorical. Significance was determined for α<.05. It was found that
women consume more milligrams of calcium per day when compared to men and they
also as have a higher exposure to lead as a result. The research also found that there is a
positive association between age and the length of time a person has been consuming
calcium supplements.
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CHAPTER 1
INTRODUCTION
Purpose of the Study
Calcium is a vital and necessary nutrient that assists in carrying out various processes
in the body. These processes include the regulation of the heart and other muscles in the
body, regulation of neural pathways by acting as a second messenger, and control of bone
and tooth strength (Power, M. et.al, 1999). In addition to the effect calcium has in these
well understood pathways, there has been research conducted in the last 10-20 years to
suggest that the level of calcium intake may also be involved in reducing cholesterol
levels by increasing the amount of HDL in the body, reducing the risk of colon cancer
and the recurrence of colon polyps, reducing tooth loss, reducing blood pressure in
people suffering from hypertension, preventing kidney stones made of calcium oxalate,
stimulating lipolysis in obese individuals to help them to lose weight, and reducing
symptoms of PMS (Moyad, M., 2003). Due to the myriad of health benefits that may
result from an increase in calcium intake in both males and females, it is important that
all individuals are consuming an adequate amount of calcium daily. In order to ensure
sufficient calcium in their diets, many people in this country take calcium supplements.
As a result of taking calcium supplements people may also be exposed to increased
amounts of lead due to the existence of lead in calcium supplements. There is conflicting
evidence that shows that calcium can be used as a protective agent against lead
absorption in rats (Fullmer, C. and Rosen, J., 1990) and in pregnant women (Ettinger, A.
et.al, 2009) but there is other research that suggests that calcium supplement intake may
cause individuals who are taking the supplements, to minimally increase their exposure to
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lead due to the amount found in the supplements (Gulson, B., et.al., 2001, Gulson, B.,
et.al., 2003, and Ross, E., et.al (2000). Since there is conflicting research on the topic and
a limited understanding of the calcium/ lead pathway in the body, it is important to gain
as much of an understanding of the rate of exposure to lead and usage of calcium by
adults consuming calcium supplements. Currently the United States Environmental
Protection Agency has not set an acceptable level of lead that individuals can be exposed
to (ATSDR, 2007) which means that even a minimal exposure to lead is too great when
one considers the number of adverse health effects associated with lead exposure, which
include: encephalopathy, high blood pressure, decreased glomerular filtration rate,
neurobehavioral and neuropsychological problems, reduced fertility, cancer, and death
(ATSDR, 2007). Therefore it is important to understand the average potential intake of
lead that an individual may be consuming as a result of taking calcium supplements in
order to understand the possible amount of lead exposure for calcium supplement taking
adults in the Las Vegas valley in order to determine whether or not that is an acceptable
level of lead exposure considering the numerous health benefits of taking calcium
supplements.
Overall, this research project will seek to understand whether or not there is a specific
demographic of people that are consuming more calcium supplements than others and if
they have an increased amount of lead exposure as a result. The population of interest for
this research project is adult males and females ages 18 and above because these
individuals are members of the adult population that could benefit from increasing their
calcium intake through the use of calcium supplements and multivitamins. This research
project will collect data on those who take calcium supplements and those who do not
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take calcium supplements, and compare their reasons for taking supplements and their
knowledge of the potential for increased lead exposure. It is expected that Caucasian
females will have an increased use of calcium supplements due to the knowledge that this
group is more likely to suffer from osteoporosis in old age than other groups.
The Specific Aims of this project are:
1. To find out the average amount of calcium being consumed by individuals in the
study.
2. To find out the average duration of time that these individuals have been
consuming calcium supplements.
3. To find out if one group of individuals is more likely than others to consume
calcium supplements.
4. To find the average amount of lead individuals in the Las Vegas valley may be
exposed to. (This calculation is an estimate based on values obtained by
researchers in previous research and as a result, this research project will not
differentiate average lead consumption by type of supplement.)
5. To find out reasons why certain individuals may choose not to take calcium
supplements.

Significance of Study
The main purpose of this study is to explore the trade-off between the benefits of
calcium vs. the potential lead exposure among people who take these supplements. This
research project will seek to understand what demographic of people are more likely to
take calcium supplements and if they can consume enough calcium supplements to cause
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a potential health problem due to the presence of lead in the supplements. The
aforementioned specific aims of this project will be considered in hopes of understanding
these relationships. This study will look at whether or not one group is more likely than
another to consume calcium supplements in order to have a foundation for other research
to determine the reasons why the other groups are not consuming as much calcium so that
all demographics within the US understand the overall benefits of taking calcium
supplements. This research project also takes into account the reasons people gave for not
taking calcium supplements in an attempt to assist in the process of understanding these
reasons. It is also important to see how long and how much calcium individuals are
consuming from calcium supplements in order to gain an understanding of whether the
usage is long term or short term and whether individuals are consuming a high enough
amount of calcium to have an effect on their overall health. The U.S. Surgeon estimates
that people aged 9-18 should be consuming 1300 mg calcium/day, 19-50 1000 mg/day,
and 51 and above 1200mg/day (U.S. Surgeon General, 2004). In addition to collecting
this information, it is also important to find out the average exposure to lead by
individuals consuming all types of calcium supplements since calcium supplements are
one of the most popular agents used by individuals to prevent or treat calcium deficiency
and because of the health risks associated with lead consumption.
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CHAPTER 2
LITERATURE REVIEW
Calcium and its Significance to the Human Body
Calcium is a bivalent cation that is used in a lot of different biochemical reactions that
aid the body in carrying out numerous processes. Its wide usage and necessity to the body
has caused the scientific community to refer to calcium as a nutrient or substance that is
vital to the everyday functioning of the body. Calcium can be found in various forms in
nature, yet once stored in the human body, it is primarily found in the teeth and bones
(Power, M., et.al 1999 and Sunyecz, J. 2008). The abundance of calcium in the teeth and
bones highlights its importance to the human body, especially to these structures.
Calcium is widely used in the body as a second messenger, a substance used to signal
various processes in the body, such as muscle contraction and maintenance of normal
heart contractions and to maintain strong and healthy bones and teeth (Power, M. et. al
1999). Without adequate amounts of calcium from the diet, also known as hypocalcemia,
adverse health reactions can affect the overall quality of life of the individual suffering
from hypocalcemia. These adverse reactions can include tetany, which is prevented by
calcium and can lead to death due to a lack of oxygen that is traveling to the brain, tooth
loss and osteoporosis or osteopenia, both of which result from bone loss (Power, M., et.al
1999 and Moyad, M., 2003). Bone is broken down in response to inadequate amounts of
calcium in the blood. In order to break down bone, the body produces increased amounts
of parathyroid hormone and osteoclasts which leads to higher levels of calcium in the
blood (Power, M., et. al 1999 and Sunyecz, J., 2008). One of the causes of this reaction is
an inadequate consumption of calcium from the diet. In order to prevent these adverse
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health reactions the US Surgeon General has set recommended daily consumption rates
of calcium, by age, 1300mg/day aged 9-18, 1000 mg/day aged 19-50, and 1200mg/day
age 51 and above (US Surgeon General, 2004).
In addition to the well understood effects that calcium has on the bone, teeth, and
muscles, there has been research conducted in the last 20 years to suggest that calcium
may also be involved in regulating other processes in the body such as hypertension,
colon cancer, obesity, hypercholesterolemia, and Pre- menstrual syndrome (Moyad, M.,
2003). Hypertension is known as high blood pressure and it affects 24% of Americans
every year (Mayad, M., 2003). If it is not regulated, it can lead to cardiovascular disease
and can ultimately cause death. Research has shown that increased consumption of
calcium in individuals suffering from hypertension may decrease blood pressure in those
individuals. With respect to colon cancer, it is the second leading cause of cancer death
that affects both males and females (National Center for Health Statistics, 2011).
Research has shown that calcium consumption may reduce the risk of recurring polyps
and reduce the risk for developing colon cancer in general (Moyad, M., 2003). Obesity is
a growing problem in this country, and can lead to diabetes type II as well as
hypertension. Calcium may stimulate lipolysis in people suffering from obesity and
reduce their weight (Moyad, M., 2003). Hypercholesterolemia, also known as high
cholesterol, is a significant health problem in this country that results from high amounts
of LDL (low density lipoprotein) and low levels of HDL (high density lipoprotein)
(Moyad, M., 2003). Without reducing cholesterol levels, plaques can develop in the
arteries and veins which may lead to cardiovascular disease and death. Research has
shown that calcium intake can lead to increased amounts of HDL which would result in
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decreased levels of cholesterol in the blood (Moyad, M., 2003). Pre- menstrual syndrome,
commonly known as PMS, disrupts the lives of many women in this country each year.
Calcium consumption may reduce PMS symptoms, such as pain, water retention, and
food cravings (Moyad, M., 2003). Due to the long list of benefits associated with calcium
intake, it is important that all Americans, especially those aged 18 and above are
consuming adequate amounts of calcium on a daily basis. Yet the question persists of
whether or not these benefits outweigh the problems associated with consuming lead that
may be found in calcium supplements.

Lead and its Relationship to Calcium
Lead is a very toxic substance that can cause a number of adverse health effects
which includes both cancer and death if absorbed in very high quantities (ATSDR, 2007).
The US EPA has classified lead compounds in the B2 class for possible carcinogens
(California EPA, 2002). According to the EPA, acute exposure to lead can cause
dullness, irritability, poor attention span, epigastric pain, constipation, vomiting,
convulsions, coma, and death in adults (ATSDR, 2007), whereas chronic exposure to lead
can cause cardiovascular effects, musculoskeletal effects, renal effects, cataracts,
neurobehavioral effects, as well as others in adults. Due to the number of adverse health
effects of lead, the California EPA has determined that the amount of lead that can be
consumed on a daily basis is 8.5x10-3 mg of lead/ kg of substance and the US EPA
refuses to set an RfD, also know as reference dose, for inorganic lead because adverse
health effects can occur at very low levels, in which case an allowable level of lead
exposure can not been determined (California EPA, 2002 and ATSDR, 2007). According
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to the US EPA an RfD “…is an estimate…of a daily exposure to the human population
(including sensitive subgroups) that is likely to be without an appreciable risk of
deleterious effects during a lifetime. The RfD is generally expressed in units of
milligrams per kilogram of bodyweight per day (mg/kg/day)” (EPA, 1993).
The danger posed by lead is inherent in its ability to be absorbed into the body, by
various tissues and organs, including the liver, kidneys, brain, bone, and in the blood
(ATSDR, 2007). One of the problems with lead absorption is that once it is absorbed, it
can stay in the body and cause chronic health effects over an unknown period of time.
According to the ATSDR 94% of the body’s total burden of lead can be found in the
bones. This poses a potential problem because the half-life of lead in the body can be
anywhere from 30 days to 27 years due to the added absorption of lead by the bones
(ATSDR, 2007). This is a problem because if lead is not quickly being removed from the
body, it can accumulate in the bone and release at any time over the course of an
individual’s life. Once released from the bones, lead enters into the blood and can flow to
other tissues and organs. Some studies have suggested that the release of lead from the
bones to the blood may happen via diffusion once the bones’ affinity for calcium is
stronger than its desire for lead (ATSDR, 2007). Studies have shown that by increasing
the uptake of calcium, lead absorption is decreased (ATSDR, 2007), which may suggest
that increased calcium uptake may increase the amount of lead in the blood. Once
released into the blood, lead can flow into various parts of the body using iron, calcium
channels, and transport proteins to transport itself into various parts of the body and
disrupt normal functioning (ATSDR, 2007). The long half-life of lead makes it difficult
to get rid of once it has been absorbed into the body. The only true way to prevent the
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accumulation of lead in the body and the health effects associated with chronic and acute
exposure to lead is to eliminate an individual’s overall exposure to lead.
The federal government has put into affect various cautions to prevent exposure to
lead and researchers have performed various studies to make sure that substances like
calcium supplements are not violating the guidelines that have been set. In 2000, a study
was published, which looked at calcium supplements and whether or not they met the
1999 criteria for acceptable lead levels in California (Scelfo, G. and Flegal, R., 2000).
The acceptable level of lead per day was set at 1.5 µg per daily dose of calcium.
Approximately, two-thirds, or 91, of the supplements tested, failed to meet the new
criteria. The California standard is one of the few that has been published on this topic,
and is actually fairly lineate, considering that the desired level for lead consumption, set
by the Agency for Toxic Substances and Disease Registry, is 0µg per day (ATSDR,
2007). The inability for certain products to adhere to this, somewhat lineate, standard
could prove to be potentially problematic for all US citizens if a conclusive link is found
between the use of calcium supplements and lead exposure. Currently, there is conflicting
evidence as to whether or not lead poses a potential health risk in the presence of calcium
due to the fact that there may be a decrease in the absorption of lead in the presence of
calcium (Gulson, B., et.al., 2001; Gulson, B., et.al., 2003; Gulson, B., et.al. 2006). The
problem with the absorption of lead by humans is two-fold. It depends both on current
exposures to lead as well as a cumulative exposure which is due to the absorption of lead
over time. One study which looked at blood lead levels in adults showed higher levels of
lead absorption in the elderly and immigrants who come from countries that still use
leaded fuel, which gives ammunition to the claim of a potential cumulative absorption of
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lead in the human body (McKelvey, W., et.al., 2007). Therefore any absorption of lead in
the body poses a potential risk to the individual consuming the lead, and could lead them
to suffer any number of adverse health effects due to their lead exposure whether from a
chronic or current source. The elderly seem to be one of the populations most at risk for
lead consumption due to their potential cumulative absorption of lead and increased use
of calcium supplements to combat such diseases as osteoporosis.
The risk posed by calcium supplements seems to be dependent on the source of the
supplement. There are approximately 5 different sources of calcium supplements for
adult consumption, not including milk, which include dolomite, refined, chelated, oyster
shell, and bonemeal. Based on previous studies, there appears to be a stratification of lead
consumption based on the source of the calcium supplement (Amarasiriwardena, D.,
et.al., 1998; Ross, E., et.al. 2000; Scelfo, G. and Flegal, R., 2000; Diment, M., et.al.,
1995; Bourgoin, B., et. al., 1993). There is conflicting evidence as to which type of
supplement exposes individuals to the highest amount of lead, but the more natural
sources, such as bonemeal and oyster shell, seem to garner the highest exposure.
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CHAPTER 3
METHODOLOGY
Research Design
This study is a retrospective study that uses a combination of data collection and
previous research in an attempt to ascertain the factors that influence calcium supplement
usage in Las Vegas, NV. The hypothesis for this study is that the benefits of using
calcium supplements will influence the frequency in which people are using calcium
supplements. It is also assumed that factors such as age, sex, and race will influence the
rate of consumption because of the perceived benefits of calcium usage for people of a
specific age, sex, or race. In addition the aforementioned variables length of usage of
supplements or multivitamins, consumption rate, and reason for taking calcium
supplements, or multivitamins, was collected.
The data was collected using a survey which contained 11 questions which were
believed to give a good understanding of calcium consumption in the Las Vegas valley,
as well as the demographic data on the individuals consuming the supplements.
Individuals age 18 and above were asked to participate in the survey, if the individual
wanted to participate in the survey, he or she was allowed to participate whether or not he
or she was presently taking calcium supplements or multivitamins that contain calcium.
Once the data was collected individuals were separated into three groups to get a better
understanding of the data, those who were presently taking calcium supplements (these
individuals answered yes to question 1), those who did not presently take calcium
supplements (these individuals answered no to question 1), and those who participated in
the survey to do comparative statistics between the two groups. The data concerning the
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amount of lead that is contained in each type of calcium supplement was collected from
various articles written by researchers in the past 14-16 years on the subject in the United
States. This data was used to estimate the average amount of lead in micrograms (µg) per
milligram (mg) of calcium, per day, in order to estimate the potential amount of lead a
person may be exposing themselves to.
A total of 250 people participated in this study. 142 participants stated that they were
presently taking calcium supplements. 108 individuals surveyed replied that they were
not taking calcium supplements, with varying reasons for not taking them. Participants
were surveyed in front of grocery stores and inside of various malls within the Las Vegas
valley. A convenience sample was used in order to obtain a large enough sample size of
people to participate in the survey so that statistics could be computed for the individuals
who were and those that were not participating in the survey. The locations for data
collection were selected in order to represent the diverse population of people throughout
the Las Vegas valley.

Study Participants
As stated above, 250 individuals were surveyed. The only requirement to participate
in the study was that individuals had to be aged 18 or above. To derail recall bias, an
initial screening of various brands of calcium supplements or multivitamins with calcium
was conducted. Pictures of the different brands were taken, along with the names of
stores where it could be purchased, the type of calcium used in the supplement, and the
amount of calcium in each calcium supplement. A convenience sampling technique was
used to collect the analyzed data. Surveys were collected from participants as they were

12

walking through grocery stores and malls, around the Las Vegas valley. In some cases
permission had to be obtained from the management at certain establishments before
survey data could be collected. All data was collected within the same week from various
locations in Las Vegas with differing demographics of people. This sampling technique
was used in order to collect a variety of surveys from people of varying sexes, races, and
ages throughout the Las Vegas valley.

Measurements
The predictor variables for this study are age, sex, and race. The outcome variable is
the amount of calcium being consumed each day. The primary purpose of this study is to
explore the trade-off between the benefits of calcium vs. the potential lead exposure
among people who take these supplements. There were a number of potential
confounding variables for this study and for this reason, each of these variables, which
include age, sex, and race, were tested to see what affect, if any, they had on the
predictability of the amount of calcium an individual is consuming. By including all of
these variables in the study, it was assumed that reliability in the validity of the statistical
results could be attained. All of the analyzed data was organized into categories and
contingency tables were used to test the significance of the association between variables.
Statistical significance was assessed at α<.05. Where appropriate, 2x2 contingency table
analysis was used in order to obtain the relative risk and odds ratio for the data. The Chi
Squared Statistic was used to approximate significance.
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Data Collection
As stated above, data was collected using a survey. Once collected, the data was
organized in an excel file until it was ready to be analyzed. Once it was ready to be
analyzed, it was transferred to an SPSS file and analyzed using the correct statistical
analyses.

Data Analysis Technique
The resulting data was analyzed using contingency tables and the Chi- Squared
statistic. The statistical program known as SPSS was used to carry out the statistical
analyses. This statistical technique was appropriate since all of the data analyzed was
categorical.
Ho- The perceived benefits of taking calcium supplements does not significantly
influence the rate of usage of calcium supplements.
Ha- The perceived benefits of taking calcium supplements influences the rate of
usage of calcium supplements.

Human Subject’s protections and ethical considerations
This project was submitted to the UNLV Institutional Review Board (IRB) for
approval since this study involves work with human subjects. The project was declared
exempt due to the lack of collection of identifiable data on the research subjects as well
as the use of a survey to collect necessary data.
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CHAPTER 4
DATA ANALYSIS
Study Population
A total of 250 individuals participated in this study and the demographic
representation of this group of individuals can be found in Table I. Of those who
participated in the study, 142 individuals stated that they were currently taking calcium
supplements and 108 stated that they were not currently taking any supplements or
multivitamins with calcium. The average age for those participating in the study was
approximately 44 with ages ranging from 18 to 85. The average age for who were
currently taking calcium supplements was slightly higher at 47, with ages that ranged
from 21 to 75, and was slightly lower at 39 for those that were not currently taking
calcium supplements, with ages that ranged from 18 to 85. There were significantly more
women than men participating in the study. These women outnumbered men not only in
total number of participants in the study but there were more women who were taking or
not taking calcium supplements than their male counterparts. When looking at the
number of individuals that participated in the study by race, there were a larger number of
Caucasians, 184, that participated when compared to any other racial group, 15, 42, and 9
for Hispanics, African Americans, and Asians respectively.
Once all of the initial demographic data was collected, preparations were made in
order to test for the significance of some of the demographic data for the entire study
population. Since much of the data is categorical, age was also categorized in order to
carry out a Chi-Square Goodness of fit test and race was separated into two groups,
Caucasian and Other, in order to try to minimize the number of counts below 5 and
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Table1. Descriptive statistics for all of the participants in the study
Variable
# of participants
Males
Females
Average age ±SD
Caucasian
Hispanic
African American
Asian

Total
250
94
156
43.86±14.29
184
15
42
9

Answered Yes
142
47
95
47.42±13.97
105
9
24
4

Answered No
108
47
61
39.14±13.36
79
6
18
5

prevent the necessity of using Yates’ Correction if more than 20% of the counts were
under 5. Contingency Tables were created and the results of the significance tests and
risk estimates can be found in Table 2. Significance was determined at a level below.05.
When analyzing the relationship between Sex and Race, significance was not found. Yet
Men were .932 times as likely as women to be Caucasian and the probability of being a
race other than Caucasian was 1.052 times more likely if the individual was a man rather
than a women. Another analysis was conducted between race and age, and no
significance was found between those two variables for the entire study population.

Table 2. Overall Statistics for the entire study population along with the variable
used to group the data.
Contingency
table variables
Sex (Male,
Female) vs. Race
(Caucasian,
other)
Race (Caucasian,
other) vs. Age
Categories

Test Statistic

P-value

Odds Ratio

Chi Square= .057

.812

.932 (Male and
Caucasian)

Relative
Risk
1.052 (Other
and Male)

Chi Square= 2.816

.728

N/A

N/A
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Analysis of Individuals Taking Calcium Supplements
After analyzing the demographic data for the entire study, the next task involved
analyzing the data collected for those individuals currently taking calcium supplements.
The first part of this analysis involved obtaining a description of the data collected, which
is found in Table 3 and the second part of the analysis involved a statistical analysis of

Calculation
Scelfo, G. and Flegal, R. report the amount of lead in refined calcium supplements as .73±1.60
µg/g in 37 brands.
Amarasiriwardena, D., et.al report the amount of lead in refined calcium supplements as .6± .1,
.8±.1, .8±.1, and .2±.1 in 4 brands.
Calculation- .73 x 37= 27.01
8x4=3.2

.8x4=3.2 .6x4=2.4

n total=53
.2x4=.8

27.01 +2.4 +3.2 +3.2+ .8=36.61
36.61/53=.69
SD= √(.12 +.12+ .12+.12+1.62)/5 =.32

Figure 1- Example of calculation of lead exposure mean and standard deviation for
refined calcium sources

the variables obtained from the survey for those individuals who were taking calcium
supplements carried out on this data, which can be found in Table 4. The data in Table 3
has been organized so that the data for each variable is separated by both the sex and race
of those individuals that fall within the listed categories. The table is designed in this
way, in order to give a better understanding of the type of supplements individuals are
taking, the average length of time they have been taking supplements, the average
number of supplements being taken each day, the amount of calcium individuals are
taking daily as well as the potential lead exposure that an individual is exposed to
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Table 3. Type of supplements participants are taking by type as well as the average
amount of calcium, average potential lead threat, average length of time individuals
have been taking supplements, and average number of supplements individuals are
taking separated by sex and race.
Variable
Do not know type
of supplement
they’re taking
Dolomite
(Calcium
Magnesium
Carbonate)
Refined Calcium
(Calcium
Carbonate,
Calcium
Phosphate, and
Calcium
Chloride)
Oyster Shell
(Natural Calcium
Carbonate)
Chelated
(Calcium citrate,
calcium malate,
calcium,
gluconate,
calcium lactate,
calcium aspartate,
calcium ascorbate,
calcium stearate,
calcium fumarate,
and calcium
lysinate)
Bonemeal
(hydroxyapetite)
Average Length
of time taking
supplements
(months)
Average number
of supplements
taken daily
Average amount
of calcium taken
daily (mg)
Average Potential
lead consumption
µg lead/mg
calcium

Total
Participants
10

Female

Male

Caucasian

Hispanic

Asian

0

African
American
2

6

4

8

0

0

0

0

0

0

0

112

75

37

82

8

19

3

6

4

2

6

0

0

0

9

5

4

4

1

3

1

5

5

0

5

0

0

0

83.45±
85.53*

87.53±
92.17*

70.46±
68.26*

84.10±
82.80*

52.78±
71.66*

85.95±
106.32*

75±
52.19*

1.57±
.87*

1.62±
.88*

1.30±
.56*

1.53±
.81*

1.28±.
44*

1.50±
.86*

2.00±
1.15*

462.54±
347.62*

519.37
±
339.16
*
.3738±
.2965*

343.63
±
338.56
*
.2268±
.2610*

483.94±
341.62*

281.11±
166.67*

446.18±
427.33*

437.5±
281.0*

.3485±
.3036*

.1828±
.0866*

.2804±
.2961*

.2939±
.2033*

.3248±
.2926*

*= Standard Deviation
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based on the amount of calcium he or she is taking. One of the first steps to organizing
the data was to determine the potential lead exposure. This was done, by first collecting
data from a number of different scientific papers (Amarasiriwardena, D., et al 1998;
Scelfo, G. and Flegal, A. 2000) that indicated the level of lead that could be found in
specific types of calcium supplements. This data was extracted from the articles and used
to compute the average and standard deviation of lead found in those supplements. An
example of this calculation for refined calcium can be found in Figure 1. The resulting
averages were used to compute the expected lead exposure, and it was assumed that the
same amount of lead would be present in calcium supplements today. The amount of lead
estimated to be present in each type of calcium supplement is: .69 ± .32 for refined
sources (calcium carbonate and calcium phosphate), .95 ± .27 for oyster shell (natural
calcium carbonate), .53 ±.27 for chelated sources (gluconate, lactate, malate, citrate,
aspartate, ascorbate, stearate, fumarate, and lysinate), and .1.43 ± .28 for bonemeal
calcium (hydroxyapetite). There were no participants taking dolomite, also known as
calcium magnesium carbonate. Individuals who didn’t know the type of calcium they
were taking, or if the type of calcium could not be found by research, were omitted from
the columns looking at the average values for the amount of calcium taken each day and
the potential lead exposure since there was no way to compute this data without knowing
the exact supplements being taken by participants. 10 individuals were omitted from this
analysis.
On further analysis of Table 3 a number of trends stand out. There are a lot of
individuals taking refined calcium compared to those taking the other types of calcium,
either calcium carbonate or calcium phosphate. It also appears that women seem to be
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taking more supplements than men. When looking at the data by race, Caucasians are
taking the majority of the supplements. Men and women seem to be taking supplements
for seventy plus months on average although women appear to be taking the supplements
for a longer period of time. When differentiating by race, it appears that all of the racial
groups have been taking supplements for a long period of time, at least 70 months, except
for Hispanics who have been taking them for almost 53 months on average. On average
African Americans have been taking supplements for the longest period of time
compared to the other groups, about 86 months, although Caucasians are very close to
this average with 84 months. Everyone appears to be taking between 1-2 supplements
each day, although Asians are the only ethnic group taking two supplements per
day on average. When it comes to the amount of calcium being consumed daily, women
are taking significantly more calcium than their male counterparts. When looking at
racial differences, Hispanics are taking a lot less calcium than the other racial groups.
When looking at a potential lead exposure, women seem to be exposed to more lead than
men. Caucasians appear to be exposed to the most lead, whereas Hispanics appear to be
exposed the least. Table 5 indicates that individuals aged 51 and above are consuming
more calcium than those aged 19-50. The Shapiro- Wilks test for normality was used to
test whether or not the data was normally distributed. Normality was not found for any of
the above mentioned continuous variables, even after attempting to transform the data
using the log and quadratic functions. Therefore non parametric tests were used to
analyze the continuous data variables, such as age, length of time taking supplements,
number of supplements being taken daily, amount of calcium being taken daily, and daily
lead exposure. The other variables in the data set are categorical variables and the Chi
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Table 4. Statistics for individuals who said that they take calcium supplements or
multivitamins with calcium along with the variable used to group data.
Test Variables
Race (Caucasian,
other) vs. Age
Sex (male, female)
vs. Race
(Caucasian, other)
Sex (male, female)
vs. type
supplement
(Refined, other)
Age vs. Type
supplement
(Refined, other)
Race (Caucasian,
other) vs. Type
(Refined, other)
Length of time
taking supplements
vs. sex
Race (Caucasian,
other) vs. length of
time taking
supplements
Sex vs. Amount of
Supplements taken
daily
Race (Caucasian,
other) vs. Amount
of Supplements
taken daily
Race (Caucasian,
other) vs. Potential
lead exposure
Sex vs. Potential
lead exposure
Age Categories vs.
length of time
taking supplements
Age Categories vs.
Amount of
Calcium taken each
day
Age Categories vs.
Potential Lead
exposure

Test Statistic
Z=-.451

P-value
.652

Odds Ratio
N/A

Relative Risk
N/A

Chi Square- .508

.476

.753 (Male and
Caucasian)

1.230 (Other
and Male)

Chi Square- .30

.862

1.077 (Male and
Other)

1.059 (Other
and Male)

Z= -.347

.729

N/A

N/A

Chi Square- .375

.540

1.339 (Caucasian
and Other)

Z=-1.132

.258

N/A

1.259 (Other
and
Caucasian)
N/A

Z=-.615

.539

N/A

N/A

Z=-3.788

<.001

N/A

N/A

Z= 1.092

.275

N/A

N/A

Z=-1.261

.207

N/A

N/A

Z=-3.950

<.001

N/A

N/A

Z=18.71

.002

N/A

N/A

Z=8.915

.112

N/A

N/A

Z=9.755

.082

N/A

N/A
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Square analysis was used to calculate statistical significance for these variables.
Significance was determined at an α<.05.
Table 5. Average Amount of Calcium Taken by people in age categories
Age

Number of people

19-50
51 and above

82
60

Amount of Calcium
consumed per day
mg
421.05±332.8
514.58±361.47

Table 4 shows results of the statistical analyses for all of the variables used to
describe the participants that were taking calcium supplements or multivitamins. The first
set of data was analyzed using the Chi-Square goodness of fit test. The data was
organized into contingency tables and the categorical data was then analyzed using the
Chi-Square analysis. This data, along with the p-value, odds ratio, and relative risk (if
attainable) were reported in Table 4. The second part of the analysis used the Mann
Whitney U test to test for significance between a few categorical and continuous
variables. For some of the analyses age is assessed as a categorical variable and for others
it is used as a continuous variable. This distinction comes about because age could not be
used as a categorical variable when using the Chi-Square test because more than 20% of
the counts were less than 5 each time age was used as a categorical variable and the Yates
correction wasn’t used to correct this calculation. Instead the Mann Whitney test was
used to assess the relationship with age being used as a continuous variable. Statistical
significance was found to be present in three of the analyses, Sex vs. the amount of
Calcium taken each day, women are higher than men, Sex vs. the amount of potential
lead exposure, women are higher than men, and age categories vs. the length of time
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taking supplements, the older the participants the longer the amount of time they have
been taking calcium supplements until the participant reaches approx. 70 and older and
the average amount of time taking the supplements decreases. The odds ratio and relative
risks were tabulated for 3 of the relationships and it was found that the odds of being
male while also being Caucasian was .753. The probability of being a race other than
Caucasian is 1.230 times higher for males than for females. The odds of being a male
while not consuming refined calcium, is 1.077. The probability of using a type of calcium
other than refined is 1.059 times more likely for males than females. The odds of being
Caucasian while using a type of supplement that is not refined, is 1.339. The probability
of using a type of calcium supplement other than refined is 1.259 times more likely for
Caucasians than for other races.
Analysis Individuals Not Taking Calcium Supplements
After analyzing the data for the individuals currently taking calcium supplements, it
was necessary to look at the reasons why people were not taking calcium supplements
and whether or not there were any significant findings for those individuals who were not
taking calcium supplements. Table 6 looks at reasons why people were not taking
calcium supplements and it separates the data by sex and age. The top five reasons
whyindividuals were not taking calcium supplements were #1 because the individuals
had no reason, #2 they said they got it from their diet, #3 they believed they didn’t need #
it, 4 they said that the supplements were too expensive, or #5 they never remember to
take them and therefore do not bother to try. More men than women said that they did not
need them and that they did not like pills, but more women than men said that they did
not remember to take the supplements and that they did not take them because their
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Table 6. Reasons participants gave for not taking any calcium supplements.
Reasons for not
taking
supplements
Too Expensive
No reason
Get it from diet
Do not need
them
Take Herbs
In good shape
Exercise
Do not
remember to
take them
Doctor never
recommended
Health reasons
Do not believe
in them
Never thought
about it
Do not like
pills
Makes me
hungry when
take it

Total

Female

Male

Caucasian

Hispanic

African
American

Asian

9
37
19
19

6
27
9
3

3
10
10
16

6
24
17
12

--3
--3

3
7
1
4

--3
1
----

1
1
1
9

1
1
1
7

------2

----1
8

---------

1
1
--1

---------

2

2

---

1

---

---

1

1
2

1
1

--1

1
2

-----

-----

-----

3

2

1

3

---

---

---

3

---

3

3

---

---

---

1

---

1

1

---

---

---

doctor’s never recommended that they should take them. When looking at racial
differences, the majority of each racial group was likely to give one of the top five
responses mentioned above.
The last analysis conducted on this data looked at the statistical significance of the
individuals who were not taking calcium supplements. The Shapiro-Wilks test for
normality was used to assess whether or not age was normally distributed for the data set.
Age was not found to be normal. The Mann Whitney U test was used to assess the
relationship between age and either race or sex because when age was organized into
categories, more than 20% of the counts were less than 5 and because age is not normal.
Statistical significance was assessed at an α<.05. The results of the analyses are listed in
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Table 7. In addition to the test statistic and p-value, Table 7 also contains the odds ratio
and relative risk for those relationships that allowed for it. Significance was only found
for one of the tests. This test assessed sex vs. race. Race was broken into two

Table 7. Statistics for individuals who said that they do not take any calcium
supplements along with the variable the data was grouped by.
Test Variables
Sex (Male,
Female) vs. Race
(Caucasian, other)
Sex (Male,
Female) vs. Age
Race (Caucasian,
other) vs. Age

Test Statistic
Chi-Square -6.247

P-value
.012

Odds Ratio
2.823 (Male
and Caucasian)

Z=-1.844

.065

N/A

Relative Risk
1.465
(Caucasian and
Male)
N/A

Z=-1.012

.312

N/A

N/A

categories, Caucasian vs. other. The odds of being male and Caucasian, is 2.823. The
probability of being Caucasian is 1.465 times more likely for males than females.
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CHAPTER 5
RESULTS
Discussion of Results and Conclusions
The main purpose of this study was to explore the trade-off between the benefits of
calcium vs. the potential lead exposure among people who take these supplements. This
study has shown that age plays a role in the length of time an individual spends taking
calcium supplements, which is important because long term usage of calcium is
necessary for the body to continuously receive enough calcium on a daily basis to carry
out its everyday processes and to combat the occurrence of disease. This means that if
people are educated early about the benefits of taking calcium supplements they may be
more likely to continue the habit of taking them in old age. In addition to taking calcium
over a long period of time, people also need to be consuming the proper amount of
calcium each day. According to the U.S. Surgeon General, adults aged 19-50 should
consume 1000 mg of Calcium/day and those age 51 and above should consume
1200mg/day (US Surgeon General, 2004). Based on the data reported from those who
were taking calcium supplements, individuals 51 and above are consuming more mg of
calcium than those aged 19-50, but neither group is at the level of calcium intake that
they need to be at per day, based on the US Surgeon General’s recommendations. It can
only be hoped that these individuals are consuming enough calcium from their diets to
meet these recommendations. Yet women as a group appear to be consuming more
calcium supplements than men, probably because women are more aware than men of the
benefits that they can accrue by taking calcium supplements. This explains why women
were more likely than men to be Caucasian if they were taking calcium supplements
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because Caucasian women are known to suffer from osteoporosis are encouraged to start
taking calcium supplements early in adulthood in hope of preventing osteoporosis and/or
osteopenia later in life. This also explains why men were more likely to not take calcium
supplements if they were Caucasian compared to women. This is a problem because
calcium is beneficial to both men and women, and both groups need to be made aware of
the benefits of calcium usage, especially with the proposed benefits of calcium in a
number of diseases, such as hypertension, a precursor to cardiovascular disease, the
leading cause of death in this country. Yet although there are a lot of benefits to taking
calcium supplements, the question remains as to whether these benefits outweigh the
potential for lead exposure.
It appears that the average amount of exposure to lead is highest amongst those
groups who are consuming a lot of mg of calcium, from supplements, each day, such as
women and Caucasians and is least amongst those who are taking the least amount of
calcium each day, which may cause some to conclude that taking calcium supplements is
a behavior that may cause some to suffer adverse health effects associated with lead
consumption. Yet this may not be the case. As it is still unclear as to whether or not
calcium competes with the lead found in the supplements, thus preventing the absorption
of lead by the body, and it may be some time before this question can really be answered.
In addition to this fact, the average amount of lead being consumed daily is
approximately .32µg of lead/mg of calcium which is very small. Although this amount is
small, the federal government has not set an acceptable level of lead that can be
consumed by the people of the United States. The subject of calcium supplements
containing lead is still a hot topic as just last year a scientific paper which looked at lead
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in calcium supplements, was published (Rehman, S. et.al, 2010). It seems hasty to jump
to a conclusion and decide that people should not take calcium supplements due to the
fact that they may be exposed to lead as a result of taking the supplements before it is
concluded, with a high degree of certainty, that the exposure actually poses a significant
health problem to those individuals consuming them. More research is needed in this
field to solve this dilemma, but until then people who are unable to consume enough
calcium from their diets, should be encouraged to consume calcium supplements unless
they can find a better alternative to deliver the necessary amount of calcium each day.
If people are going to be encouraged to take calcium supplements, researchers must
also understand the reasoning behind why some individuals choose not to take calcium
supplements. For this reason, data was collected to try to understand these reasons.
Statistical significance could not be assessed because the sample sizes were too small to
carry out a Chi-Square analysis, therefore the top five reasons why people chose not to
take calcium supplements was given in order to better understand them and to figure out
a solution to combat these reasons. The top five reasons are as follows: #1 no reason, #2
they said they got it from their diet, #3 they believed they did not need to take calcium
supplements, #4 they said that the supplements were too expensive, or #5 they never
remember to take them and therefore did not bother to try to take them. These reasons
give insight into potential solutions to getting people to take calcium supplements. For
those who have no reason, do not remember to take them, or do not believe they need
them, education may work best. If the public is educated about the benefits of taking
calcium supplements, they may be more likely to put more effort into getting the
supplements so that they can take them. For those individuals who say calcium
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supplements are too expensive, the above method may work to convince these
individuals to buy them in spite of the price, but if they still cannot afford them public
health projects could be put into place to help subsidize the cost of the supplements so
that everyone can have the ability to take calcium supplements, no matter their socioeconomic status. For those who say they get the necessary amount of calcium from their
diet, they should also be educated about the benefits of calcium consumption and the
daily recommended amount of calcium to be consumed for their age group. They should
also be encouraged to calculate their own calcium consumption rate to make sure that
they are meeting this requirement.

Limitations and Recommendations for Further Study
There were a few limitations to this study. One of these limitations was a small
sample size. Due to the sample size obtained, trends based on race could not be
calculated. A second limitation to the study was the use of previous data to determine
lead burden, instead of determining it in the lab by using approved methods to figure out
the amount of lead in calcium supplements. A third limitation to this study is the
omission of individuals who refused to participate in this study. A final limitation was the
confinement of the study to the Las Vegas valley. The demographic with the Las Vegas
valley may not be similar to others throughout the country, making the data difficult to be
generalizable to a larger segment of the population of the United States. Further research
is necessary to verify whether or not the data is truly representative of the calcium
consumption rate and potential lead exposure for individuals consuming calcium
supplements in the Las Vegas Valley and throughout the United States. Further study will
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also be necessary in order to continue to understand the reasons why people chose to take
or not to take calcium supplements.
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APPENDIX
SUPPLEMENTAL DATA
Contingency Tables
Yes and No Only

Crosstabs
[DataSet1] E:\Tanesha Flash drive\Thesis\Thesis yes and no 2.sav
1=male, 2=Female * 1=Caucasian, 2=Other (African American, Asian,
Hispanic) Crosstabulation
Count
1=Caucasian, 2=Other (African
American, Asian, Hispanic)
1.00

2.00

Total

1=male, 2=Female 1

68

26

94

2

115

41

156

183

67

250

Total

Chi-Square Tests

Value
Pearson Chi-Square
Continuity Correction
Likelihood Ratio

Exact Sig. (2-

Exact Sig.

sided)

sided)

(1-sided)

a

1

.812

.008

1

.928

.057

1

.812

.057
b

df

Asymp. Sig. (2-

Fisher's Exact Test
Linear-by-Linear

.883
.057

1

.812

Association
N of Valid Cases

250

a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 25.19.
b. Computed only for a 2x2 table

31

.462

Symmetric Measures
Asymp. Std.
Value
Interval by

Error

a

Approx.
b

Approx. T

Sig.

Pearson's R

-.015

.063

-.237

.813

c

Spearman Correlation

-.015

.063

-.237

.813

c

Interval
Ordinal by
Ordinal
N of Valid Cases

250

a. Not assuming the null hypothesis.
b. Using the asymptotic standard error assuming the null hypothesis.
c. Based on normal approximation.

Risk Estimate
95% Confidence Interval
Value
Odds Ratio for 1=male,

Lower

Upper

.932

.524

1.658

.981

.839

1.147

1.052

.692

1.601

2=Female (1 / 2)
For cohort 1=Caucasian,
2=Other (African
American, Asian,
Hispanic) = 1.00
For cohort 1=Caucasian,
2=Other (African
American, Asian,
Hispanic) = 2.00
N of Valid Cases

250
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Crosstabs
[DataSet4] E:\Tanesha Flash drive\Thesis\Thesis yes and no 2.sav
1=Caucasian, 2=Other (African American, Asian, Hispanic) * 1=18-29, 2=30-39, 3=40-49, 4=5059, 5=60-69, 6= 70 and above Crosstabulation
Count
1=18-29, 2=30-39, 3=40-49, 4=50-59, 5=60-69, 6= 70 and
above
1

2

3

4

5

6

Total

1=Caucasian,

1.00

33

39

45

36

19

11

183

2=Other (African

2.00

14

19

12

11

8

3

67

47

58

57

47

27

14

250

American, Asian,
Hispanic)
Total

Chi-Square Tests
Asymp. Sig. (2Value

df

sided)

a

5

.728

2.833

5

.726

Linear-by-Linear Association

.711

1

.399

N of Valid Cases

250

Pearson Chi-Square

2.816

Likelihood Ratio

a. 1 cells (8.3%) have expected count less than 5. The minimum expected
count is 3.75.

Crosstabs
[DataSet4] E:\Tanesha Flash drive\Thesis\Thesis yes and no 2.sav
1=Caucasian, 2=Other (African American, Asian, Hispanic) * 1=18-29, 2=30-39, 3=40-49, 4=5059, 5=60-69, 6= 70 and above Crosstabulation
Count
1=18-29, 2=30-39, 3=40-49, 4=50-59, 5=60-69, 6= 70 and
above
1

2

3

4

5

6

Total

1=Caucasian,

1.00

33

39

45

36

19

11

183

2=Other (African

2.00

14

19

12

11

8

3

67

47

58

57

47

27

14

250

American, Asian,
Hispanic)
Total

33

Chi-Square Tests
Asymp. Sig. (2Value

df

sided)

a

5

.728

Likelihood Ratio

2.833

5

.726

Linear-by-Linear

.711

1

.399

Pearson Chi-Square

2.816

Association
N of Valid Cases

250

a. 1 cells (8.3%) have expected count less than 5. The minimum expected
count is 3.75.

Yes Only

Crosstabs
[DataSet3] C:\Documents and Settings\Ron B\My Documents\Tanesha Flash
drive\Thesis\Thesis yes only.sav
1=male, 2=Female * 1= Caucasian, 2= Other (Hispanic, Asian, African
American) Crosstabulation
Count
1= Caucasian, 2= Other (Hispanic,
Asian, African American)
1.00
1=male, 2=Female

Total

2.00

Total

1.00

33

14

47

2.00

72

23

95

105

37

142
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Chi-Square Tests

Value
Pearson Chi-Square
Continuity Correction
Likelihood Ratio

Exact Sig. (2-

Exact Sig.

sided)

sided)

(1-sided)

df
a

1

.476

.259

1

.611

.501

1

.479

.508
b

Asymp. Sig. (2-

Fisher's Exact Test
Linear-by-Linear

.544
.504

1

.478

Association
N of Valid Cases

142

a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 12.25.
b. Computed only for a 2x2 table

Risk Estimate
95% Confidence Interval
Value
Odds Ratio for 1=male,

Lower

Upper

.753

.345

1.646

.926

.745

1.152

1.230

.699

2.165

2=Female (1.00 / 2.00)
For cohort 1= Caucasian,
2= Other (Hispanic,
Asian, African American)
= 1.00
For cohort 1= Caucasian,
2= Other (Hispanic,
Asian, African American)
= 2.00
N of Valid Cases

142

35

.303

Crosstabs
[DataSet4] E:\Tanesha Flash drive\Thesis\Thesis yes and no 2.sav
1=Caucasian, 2=Other (African American, Asian, Hispanic) * 1=18-29, 2=30-39, 3=40-49, 4=5059, 5=60-69, 6= 70 and above Crosstabulation
Count
1=18-29, 2=30-39, 3=40-49, 4=50-59, 5=60-69, 6= 70 and
above
1

2

3

4

5

6

Total

1=Caucasian,

1.00

33

39

45

36

19

11

183

2=Other (African

2.00

14

19

12

11

8

3

67

47

58

57

47

27

14

250

American, Asian,
Hispanic)
Total

Chi-Square Tests
Asymp. Sig. (2Value

df

sided)

a

5

.728

Likelihood Ratio

2.833

5

.726

Linear-by-Linear

.711

1

.399

Pearson Chi-Square

2.816

Association
N of Valid Cases
a.

250

1 cells (8.3%) have expected count less than 5. The minimum
expected count is 3.75.

36

Crosstabs
[DataSet3] C:\Documents and Settings\Ron B\My Documents\Tanesha Flash
drive\Thesis\Thesis yes only.sav

1=male, 2=Female * 1= Caucasian, 2= Other (Hispanic, Asian, African
American) Crosstabulation
Count
1= Caucasian, 2= Other (Hispanic,
Asian, African American)
1.00
1=male, 2=Female

2.00

Total

1.00

33

14

47

2.00

72

23

95

105

37

142

Total

Chi-Square Tests
Asymp. Sig. Exact Sig. (2Value
Pearson Chi-Square
Continuity Correction
Likelihood Ratio

(2-sided)

a

1

.476

.259

1

.611

.501

1

.479

.508
b

df

Fisher's Exact Test
Linear-by-Linear

sided)

Exact Sig. (1sided)

.544
.504

1

.478

Association
N of Valid Cases

142

a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 12.25.
b. Computed only for a 2x2 table

37

.303

Risk Estimate
95% Confidence Interval
Value
Odds Ratio for 1=male,

Lower

Upper

.753

.345

1.646

.926

.745

1.152

1.230

.699

2.165

2=Female (1.00 / 2.00)
For cohort 1= Caucasian,
2= Other (Hispanic,
Asian, African American)
= 1.00
For cohort 1= Caucasian,
2= Other (Hispanic,
Asian, African American)
= 2.00
N of Valid Cases

142

Crosstabs
[DataSet3] C:\Documents and Settings\Ron B\My Documents\Tanesha Flash
drive\Thesis\Thesis yes only.sav

1=male, 2=Female * 1= Other (Don't know, Dolomite, Oyster Shell, Chelated,
Bonemeal), 3=Refined Crosstabulation
Count
1= Other (Don't know, Dolomite,
Oyster Shell, Chelated, Bonemeal),
3=Refined
1.00

3.00

Total

1=male,

1.00

11

36

47

2=Female

2.00

21

74

95

32

110

142

Total
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Chi-Square Tests

Value
Pearson Chi-Square
Continuity Correction
Likelihood Ratio

Exact Sig. (2-

Exact Sig.

sided)

sided)

(1-sided)

df
a

1

.862

.000

1

1.000

.030

1

.862

.030
b

Asymp. Sig. (2-

Fisher's Exact Test
Linear-by-Linear

1.000
.030

1

.862

Association
N of Valid Cases

142

a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 10.59.
b. Computed only for a 2x2 table

Risk Estimate
95% Confidence Interval
Value
Odds Ratio for 1=male,

Lower

Upper

1.077

.469

2.472

1.059

.558

2.009

.983

.812

1.190

2=Female (1.00 / 2.00)
For cohort 1= Other
(Don't know, Dolomite,
Oyster Shell, Chelated,
Bonemeal), 3=Refined =
1.00
For cohort 1= Other
(Don't know, Dolomite,
Oyster Shell, Chelated,
Bonemeal), 3=Refined =
3.00
N of Valid Cases

142
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.510

Crosstabs
[DataSet3] C:\Documents and Settings\Ron B\My Documents\Tanesha Flash
drive\Thesis\Thesis yes only.sav
1= Caucasian, 2= Other (Hispanic, Asian, African American) * 1= Other (Don't know,
Dolomite, Oyster Shell, Chelated, Bonemeal), 3=Refined Crosstabulation
Count
1= Other (Don't know, Dolomite,
Oyster Shell, Chelated, Bonemeal),
3=Refined
1.00

3.00

Total

1= Caucasian, 2= Other

1.00

25

80

105

(Hispanic, Asian, African

2.00

7

30

37

32

110

142

American)
Total

Chi-Square Tests

Value
Pearson Chi-Square
Continuity Correction
Likelihood Ratio

Exact Sig. (2-

Exact Sig.

sided)

sided)

(1-sided)

a

1

.540

.147

1

.701

.385

1

.535

.375
b

df

Asymp. Sig. (2-

Fisher's Exact Test
Linear-by-Linear

.650
.372

1

.542

Association
N of Valid Cases

142

a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 8.34.
b. Computed only for a 2x2 table

40

.358

Risk Estimate
95% Confidence Interval
Value
Odds Ratio for 1=

Lower

Upper

1.339

.525

3.419

1.259

.595

2.663

.940

.778

1.135

Caucasian, 2= Other
(Hispanic, Asian, African
American) (1.00 / 2.00)
For cohort 1= Other (Don't
know, Dolomite, Oyster
Shell, Chelated, Bonemeal),
3=Refined = 1.00
For cohort 1= Other (Don't
know, Dolomite, Oyster
Shell, Chelated, Bonemeal),
3=Refined = 3.00
N of Valid Cases

142

No Only

Crosstabs
1=male, 2=Female * 1= Caucasian 2=Other (Hispanic, Asian, African
American Crosstabulation
Count
1= Caucasian 2=Other (Hispanic,
Asian, African American
1.00
1=male, 2=Female

Total

2.00

Total

1.00

35

12

47

2.00

31

30

61

66

42

108

41

Chi-Square Tests

Value
Pearson Chi-Square
Continuity Correction
Likelihood Ratio

Exact Sig. (2-

Exact Sig.

sided)

sided)

(1-sided)

df
a

1

.012

5.291

1

.021

6.392

1

.011

6.247
b

Asymp. Sig. (2-

Fisher's Exact Test

.017

Linear-by-Linear

6.189

1

.013

Association
N of Valid Cases

108

a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 18.28.
b. Computed only for a 2x2 table

Risk Estimate
95% Confidence Interval
Value
Odds Ratio for 1=male,

Lower

Upper

2.823

1.236

6.446

1.465

1.087

1.975

.519

.299

.901

2=Female (1.00 / 2.00)
For cohort 1= Caucasian
2=Other (Hispanic, Asian,
African American = 1.00
For cohort 1= Caucasian
2=Other (Hispanic, Asian,
African American = 2.00
N of Valid Cases

108

42

.010

Note: Chelated=Calcium (gluconate, lactate, malate, citrate, aspartate, ascorbate, stearate, fumarate, and
lysinate

Calcium Supplement Survey
1.

Are you currently taking supplements? (Please circle one)
Yes
No
2. How long have you been taking Calcium supplements?
_______years _______months
3. In the past year, how often did you/do you take the supplements? (Please circle one)
a) Every day b) almost every day c) once a week
d) occasionally
e) rarely
4. How many supplements do you take at one time?_____________________
5. Why do you take calcium supplements?_____________________________
6. What brand of supplements do you take?____________________________
7. What type of calcium supplements are you taking? (Please circle one)
Don’t know

Dolomite (Calcium Magnesium Carbonate)

Calcium Carbonate

oyster shell
chelated (see note on top of page)

bonemeal (hydroxyapatite)

Calcium

Phosphate
8. How old are you? ___________________
9. What is your sex? (Please circle one)
Male
Female
10. How would you classify your race? ( Please circle one, if you choose other, please
fill it in)
Caucasian
Hispanic
African- American
Asian
Other:_____________________________________

Thank you
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